CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 67 filers reported holding CULLINAN ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $220,041 | -1.1% | 24,314 | +17.6% | 0.00% | – |
| Q2 2023 | $222,506 | -2.4% | 20,679 | -7.0% | 0.00% | – |
| Q1 2023 | $228,000 | +111119.5% | 22,243 | +14.7% | 0.00% | – |
| Q4 2022 | $205 | -99.9% | 19,385 | -2.6% | 0.00% | – |
| Q3 2022 | $256,000 | +10.8% | 19,909 | +10.6% | 0.00% | – |
| Q2 2022 | $231,000 | -8.7% | 17,995 | -25.6% | 0.00% | – |
| Q1 2022 | $253,000 | -18.1% | 24,172 | +20.5% | 0.00% | – |
| Q4 2021 | $309,000 | -9.4% | 20,057 | +32.5% | 0.00% | – |
| Q3 2021 | $341,000 | +63.2% | 15,139 | +86.3% | 0.00% | – |
| Q2 2021 | $209,000 | -86.9% | 8,124 | -78.7% | 0.00% | – |
| Q1 2021 | $1,592,000 | – | 38,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |